National Health Investors stock hits 52-week high at $90.58 By Investing.com

NodeGuardian · 2026-02-27T18:06:22+00:00

National Health Investors Inc. (NHI) stock rose 38.72% in a year, reaching a 52-week high of $90.58, driven by market conditions and strategic investments. It has a 4.12% dividend yield and recent acquisitions over $100 million, with Truist Securities maintaining a Buy rating and a target price of $83.

NodeGuardian

2026-02-27 18:06:22

Abstract generation in progress

National Health Investors Inc. (NHI) stock achieved a 52-week high of $90.58, reflecting a 38.72% increase over the past year and a 22.49% gain in the last six months, driven by favorable market conditions and strategic investments. The company, a healthcare REIT with a $4.3 billion market capitalization, maintains a 4.12% dividend yield and has made recent acquisitions totaling over $100 million in healthcare properties. Truist Securities has raised its price target for NHI to $83, reiterating a Buy rating, based on the company’s expansion efforts and financial projections.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.